☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
EULAR 2021
PharmaShots Interview: Eli Lilly's Dr. Lotus Mallbris Shares Insight on the Data of Taltz and Olumiant Presented at EULAR 2021
August 2, 2021
Celltrion Presents One Year Results of Yuflyma (biosimilar- adalimumab) in P-III CT-P17 3.1 Trial for Rheumatoid Arthritis at EULA...
June 3, 2021
AstraZeneca Presents Results of Anifrolumab in New Post-Hoc Analysis of P-III TULIP Study for Systemic Lupus Erythematosus at EULA...
June 2, 2021
Novartis Presents Two-Year Data of Cosentyx in P-III JUNIPERA Study for JPsA and ERA at EULAR 2021
June 2, 2021
AbbVie Presents Results of Long-Term Efficacy and Safety Analyses for Rinvoq (upadacitinib) in P-III SELECT-COMPARE Study for Rheu...
June 2, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.